Repeated influenza vaccination of healthy children and adults: Borrow now, pay later?

Epidemiology and Infection

Volumn 134, Issue 1, 2006, Pages 63-70

  Carrat, F ^a,b   Lavenu, A ^a   Cauchemez, S ^a   Delegers, S ^a  

^a INSERM   (France)

^b Groupe Hospitalo universitaire Est   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; HUMAN; INCIDENCE; INFANT; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; PROBABILITY; PUBLICATION; RECURRENT INFECTION; REINFECTION; RISK ASSESSMENT; RISK REDUCTION; SIMULATION;

EID: 30844467543     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268805005479     Document Type: Article

References (52)

1. van Essen GA, Palache AM, Forleo E, Fedson DS. Influenza vaccination in 2000: Recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003; 21: 1780-1785.
2. Nichol KL, Margolis KL, Wuorenina J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778-784.
3. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348: 1322-1332.
4. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123: 518-527.
5. Nichol KL. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med 2001; 161: 749-759.
6. Belshe RB, Mendelnan PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998; 338: 1405-1412.
7. Belshe RB, Gruber WC. Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatr Infect Dis J 2000; 19: S66-S71.
8. Halloran ME, Longini Jr. IM, Gaglani MJ, et al. Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. Am J Epidemiol 2003; 158: 305-311.
9. Nichol KL, Mendehnan PM, Mallon KP, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: A randomized controlled trial. J Am Med Assoc 1999; 282: 137-144.
10. Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995; 333: 889-893.
11. Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, Singleton JA. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep Recomm Rep 2003; 52: 1-34.
12. Harper SA, Fukuda K, Cox NJ, Bridges CB. Using live, attenuated influenza vaccine for prevention and control of influenza: Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep Recomm Rep 2003; 52: 1-8.
13. Webby RJ, Andreansky S, Stambas J, et al. Protection and compensation in the influenza virus-specific CD8 + T cell response. Proc Natl Acad Sci USA 2003; 100: 7235-7240.
14. Cox RJ, Brokstad KA, Ogra P. Influenza virus: Immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 2004; 59: 1-15.
15. Shann F. Modern vaccines. Pneumococcus and influenza. Lancet 1990; 335: 898-901.
16. Sullivan KM, Monto AS, Foster DA. Antibody response to inactivated influenza vaccines of various antigenic concentrations. J Infect Dis 1990; 161: 333-335.
17. Belshe RB, Gruber WC, Mendelman PM, et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis 2000; 181: 1133-1137.
18. Clements MI,, Murphy BR. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol 1986; 23: 66-72.
19. Ennis FA, Rook AH, Qi YH, et al. HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet 1981; 2: 887-891.
20. Gorse GJ, Belshe RB. Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination n older, chronically ill adults. J Clin Microbiol 1990; 28: 2539-2550.
21. Belshe RB, Gruber WC, Mendelman PM, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000; 136: 168-175.
22. Gill PW, Murphy AM. Naturally acquired immunity to influenza type A. Lessons from two coexisting subtypes. Med J Aust 1985; 142: 94-98.
23. Couch RB, Kasel JA. Immunity to influenza in man. Annu Rev Microbiol 1983; 37: 529-549.
24. Glezen WP, Keitel WA, Taber LH, Piedra PA, Clover RD, Couch RB. Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: Comparison to age-specific infection rates, 1978-1989. Am J Epidemiol 1991; 133: 296-304.
25. Boon AC, de Mutsert G, van Baarle D, et al. Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes. J Immunol 2004; 172: 2453-2460.
26. Haanen JB, Wolkers MC, Kruisbeek AM, Schumacher TN. Selective expansion of cross-reactive CD8(+) memory T cells by viral variants. J Exp Med 1999; 190: 1319-1328.
27. Jameson J, Cruz J, Ennis FA. Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J Virol 1998; 72: 8682-8689.
28. Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD. Protection against influenza after annually repeated vaccination: A meta-analysis of serologic and field studies. Arch Intern Med 1999; 159: 182-188.
29. Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 1997; 15: 1114-1122.
30. de Bruijn IA, Remarque EJ, Jol-van der Zijde CM, van Tol MJ, Westendorp RG, Knook DL. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. J Infect Dis 1999; 179: 31-36.
31. Keitel WA. Repeated immunization of children with inactivated and live attenuated influenza virus vaccines: Safety, immunogenicity, and protective efficacy. Semin Pediatr Infect Dis 2002; 13: 112-119.
32. Bernstein DI, Yan L, Treanor J, Mendelman PM, Belshe R. Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children. Pediatr Infect Dis J 2003; 22: 28-34.
33. Smith DJ, Forrest S, Ackley DH, Perelson AS. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci USA 1999; 96: 14001-14006.
34. Press WH, Flannery BP, Teukolsky SA, Vetterling WT. Numerical recipes in C. The art of scientific computing. Cambridge: Cambridge University Press, 1997.
35. Seber GAF, Wild CJ. Nonlinear regression. New York: John Wiley and Sons, 1989.
36. Carrat F, Valleron AJ. Epidemiologic mapping using the 'kriging' method: application to an influenza-like illness epidemic in France. Am J Epidemiol 1992; 135: 1293-1300.
37. Valleron AJ, Bouvet E, Garnerin P, et al. A computer network for the surveillance of communicable diseases: The French experiment. Am J Public Health 1986; 76: 1289-1292.
38. Carrat F, Flahault A, Boussard E, Farran N, Dangoumau L, Valleron AJ. Surveillance of influenza-like illness in France. The example of the 1995/1996 epidemic. J Epidemiol Community Health 1998; 52 (Suppl 1): 32S-38S.
39. Frank AL, Taber LH, Wells JM. Comparison of infection rates and severity of illness for influenza A subtypes H1N1 and H3N2. J Infect Dis 1985; 151: 73-80.
40. Carrat F, Sahler C, Rogez S, et al. Influenza burden of illness: estimates from a national prospective survey of household contacts in France. Arch Intern Med 2002; 162: 1842-1848.
41. Elder AG, O'Donnell B, McCruden EA, Symington IS, Carman WF. Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993-4 epidemic: Results of serum testing and questionnaire. BMJ 1996; 313: 1241-1242.
42. Monto AS, Koopman JS, Longini Jr. IM. Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. Am J Epidemiol 1985; 121: 811-822.
43. Zambon M, Hays J, Webster A, Newman R, Keene O. Diagnosis of influenza in the community: Relationship of clinical diagnosis to confirmed virological, scrologic, or molecular detection of influenza. Arch Intern Med 2001; 161: 2116-2122.
44. Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect 1993; 110: 145-160.
45. Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA. Influenza virus infections in infants. Pediatr Infect Dis J 1997; 16: 1065-1068.
46. Fine PEM. Herd immunity: History, theory, practice. Epidemiol Rev 1993; 15: 265-302.
47. Webster RG. Immunity to influenza in the elderly. Vaccine 2000; 18: 1686-1689.
48. Belshe RB. Current status of live attenuated influenza virus vaccine in the US. Virus Res 2004; 103: 177-185.
49. Reichert TA, Simonsen L, Sharma A, Pardo SA, Fedson DS, Miller MA. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epiderniol 2004; 160: 492-502.
50. Monto AS, Davenport FM, Napier JA, Francis JT. Modification of an outbreak of influenza in Tecumseh Michigan by vaccination of schoolchildren. J Infect Dis 1970; 122: 16-25.
51. Longini IM, Halloran ME, Nizam A, et al. Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: Implications for influenza epidemic control. Vaccine 2000; 18: 1902-1909.
52. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005; 23: 1540-1548.